Potassium Citrate to Prevent Age Related Bone Loss

Completed · Not applicable

Conditions studied: Osteoporosis

In brief

Osteoporosis, a disease in which the bones become weak and are more likely to break, is a major health problem in the United States. Too much acid in the body appears to be linked to loss of calcium via urine, bone loss, and muscle breakdown. The purpose of this study is to determine the effect of various doses of potassium citrate, a supplement that can neutralize acid, on bone density and muscle mass in older, healthy adults.

Key facts

Study ID

NCT00282126

Run by

University of California, San Francisco

People needed

52

Starts

2006-01-01

Last updated by the study team

2014-08-11

Who can join

Age: 55 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Good general health

You may not qualify if…

• Abnormal kidney, liver, or bone function
• Currently taking medications that might affect potassium or bone

Where it is running

• Johns Hopkins University — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.